Timo Ilari Veromaa
Presidente presso HERANTIS PHARMA OYJ
Provenienza dei contatti di primo grado di Timo Ilari Veromaa
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 32 | |
| Public Company | Pharmaceuticals: Major | 17 | |
Kemianteollisuus ry
17
| Non-Profit Organization | 17 | |
Hermo Pharma Oy
 Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd.
9
| Extinct | Pharmaceuticals: Major | 9 |
Suomen Bioteollisuus ry
3
| Private Company | 3 | |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Schering Oy
2
| Extinct | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Timo Ilari Veromaa tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NOKIA OYJ | Telecommunications Equipment | Director of Research - Fxd Inc Human Resources Officer Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder General Counsel | |
| MANNKIND CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
elbion NV
 elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | Pharmaceuticals: Major | Founder Director of Finance/CFO Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| KEMIRA OYJ | Chemicals: Specialty | Director/Board Member Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
| ORION OYJ | Pharmaceuticals: Major | Sales & Marketing Chief Executive Officer Director/Board Member Chief Executive Officer | |
| YIT OYJ | Real Estate Development | President Director/Board Member Director/Board Member | |
| KONECRANES OYJ | Trucks/Construction/Farm Machinery | Director/Board Member Director/Board Member | |
| APETIT OYJ | Food: Specialty/Candy | Director/Board Member Director/Board Member | |
| NOKIAN RENKAAT OYJ | Automotive Aftermarket | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
Orion Pharma Oy
 Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NEL ASA | Industrial Machinery | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Toronto | College/University | Undergraduate Degree Doctorate Degree | |
Mobidiag Oy
 Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Miscellaneous Commercial Services | Director/Board Member Chairman Founder Corporate Officer/Principal | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Aalto University | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| University of Helsinki | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree | |
Elinkeinoelämän Keskusliitto ry
 Elinkeinoelämän Keskusliitto ry Miscellaneous Commercial ServicesCommercial Services Elinkeinoelämän Keskusliitto ry is a business organization based in Helsinki, Finland. and has subsidiaries in Finland. The Finnish company operates as a business organization. The CEO of the private company is Jyri Jukka Häkämies. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Helsingin seudun kauppakamari | Director/Board Member Corporate Officer/Principal | ||
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer Founder | |
East Office of Finnish Industries Oy
 East Office of Finnish Industries Oy Miscellaneous Commercial ServicesCommercial Services East Office of Finnish Industries Oy operates as a business association. The private company is based in Helsinki, Finland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
MediSapiens Oy
 MediSapiens Oy Packaged SoftwareTechnology Services MediSapiens Oy provides solutions for bioinformatics analysis. It offers software and products for biological research. The firm creates customized bioinformatics software solutions to organizations; ranging from data management system, to full sample and data processing system, to an animal deoxyribonucleic acid testing service. Its products include Biond Explorer; Research Integrator; IST Online; Target Scout; and Fusion Scout. The company was founded by Sami Kalevi Kilpinen, Olli-Pekka Kallioniemi, and Tommi Pisto in 2009 and is headquartered in Helsinki, Finland. | Packaged Software | Director/Board Member Director/Board Member | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded in March 1991 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Versant EuroVentures | Chairman Chief Executive Officer | ||
| Muoviteollisuus ry | Director/Board Member Director/Board Member Chairman | ||
| CAVERION OYJ | Engineering & Construction | Chief Executive Officer Corporate Officer/Principal | |
| Aalto University School of Business | College/University | Masters Business Admin Graduate Degree | |
| Kumiteollisuus RY | Chairman Chairman | ||
Aranda Pharma Oy
 Aranda Pharma Oy BiotechnologyHealth Technology Aranda Pharma Ltd. engages in the research and development of novel small molecules to combat prostate cancer and neurodegenerative diseases. The company was founded by Anu Muona, Milla Koistinaho, Jari Koistinaho, and Gundars Goldsteins in September 2015 and is headquartered in Kuopio, Finland. | Biotechnology | Founder Director/Board Member | |
Innovestor Oy
 Innovestor Oy Investment ManagersFinance Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Innovestor Ventures Oy
 Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor Private Equity Investor | |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| Aalto University School of Science & Technology | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| Chemical Industry Federation of Finland | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Finlandia | 31 |
| Stati Uniti | 8 |
| Svizzera | 5 |
| Regno Unito | 4 |
| Germania | 3 |
Settori
| Health Technology | 21 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 4 |
| Producer Manufacturing | 3 |
Posizioni
| Director/Board Member | 519 |
| Corporate Officer/Principal | 203 |
| Chairman | 155 |
| Independent Dir/Board Member | 112 |
| Chief Executive Officer | 112 |
Contatti più connessi
| Insiders | |
|---|---|
| Andrew Schwab | 45 |
| Bradley Bolzon | 41 |
| Mahendra Shah | 35 |
| Erkki Olavi Järvinen | 31 |
| J. Kenneth Charles Knowles | 29 |
| Wolfgang Heinz Büchele | 28 |
| William Burns | 27 |
| Ismail Kola | 26 |
| Ann Hanham | 26 |
| Ingrid Atteryd Heiman | 24 |
| Ari Tapio Lehtoranta | 24 |
| James Phillips | 24 |
| Liisa Helena Harjula | 24 |
| Guido Magni | 23 |
| Mats Johan Peter Thorén | 23 |
- Borsa valori
- Insiders
- Timo Ilari Veromaa
- Connessioni Società
